We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-12.09%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.54B
AUM Growth
-$433M
Cap. Flow
-$21.4M
Cap. Flow %
-0.84%
Top 10 Hldgs %
31.88%
Holding
847
New
132
Increased
213
Reduced
233
Closed
169

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Healthcare 8.9%
3 Financials 6.63%
4 Consumer Staples 4.45%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMR icon
626
Nomura Holdings
NMR
$28.6B
$163K 0.01%
45,534
+5,103
+13% +$19.5K
NGS icon
627
Natural Gas Services Group
NGS
$501M
$161K 0.01%
+14,596
New +$186K
DBI icon
628
Designer Brands
DBI
$272M
$158K 0.01%
+12,100
New +$174K
ESTE
629
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$158K 0.01%
11,600
-9,600
-45% -$151K
IRWD icon
630
Ironwood Pharmaceuticals
IRWD
$624M
$156K 0.01%
+13,500
New +$159K
TCS
631
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$155K 0.01%
+1,660
New +$188K
PBYI icon
632
Puma Biotechnology
PBYI
$408M
$152K 0.01%
+53,500
New +$133K
SIGA icon
633
SIGA Technologies
SIGA
$226M
$152K 0.01%
+13,100
New +$118K
SSP icon
634
E.W. Scripps
SSP
$269M
$150K 0.01%
+12,000
New +$192K
CTG
635
DELISTED
Computer Task Group, Inc.
CTG
$146K 0.01%
+17,084
New +$156K
BBVA icon
636
Banco Bilbao Vizcaya Argentaria
BBVA
$140B
$144K 0.01%
31,921
+997
+3% +$5.05K
BDTX icon
637
Black Diamond Therapeutics
BDTX
$105M
$144K 0.01%
+58,500
New +$136K
CMRX
638
DELISTED
Chimerix, Inc.
CMRX
$142K 0.01%
+68,100
New +$219K
AMRX icon
639
Amneal Pharmaceuticals
AMRX
$5.74B
$141K 0.01%
+44,200
New +$160K
REAL icon
640
The RealReal
REAL
$1.37B
$137K 0.01%
+55,137
New +$245K
ORGO icon
641
Organogenesis Holdings
ORGO
$313M
$136K 0.01%
+27,900
New +$172K
CRWS icon
642
Crown Crafts
CRWS
$32M
$134K 0.01%
+21,469
New +$134K
CRBU icon
643
Caribou Biosciences
CRBU
$162M
$128K 0.01%
+23,500
New +$180K
ALXO icon
644
ALX Oncology
ALXO
$272M
$125K ﹤0.01%
+15,510
New +$169K
UNIT
645
Uniti Group
UNIT
$2.68B
$125K ﹤0.01%
13,287
HROW icon
646
Harrow
HROW
$1.56B
$123K ﹤0.01%
16,837
+1,515
+10% +$10.2K
RYTM icon
647
Rhythm Pharmaceuticals
RYTM
$7.04B
$122K ﹤0.01%
+29,500
New +$161K
ANNX icon
648
Annexon
ANNX
$868M
$110K ﹤0.01%
+29,086
New +$88.9K
XLO icon
649
Xilio Therapeutics
XLO
$54.6M
$107K ﹤0.01%
+2,617
New +$138K
CAPR icon
650
Capricor Therapeutics
CAPR
$1.15B
$104K ﹤0.01%
+29,801
New +$106K

Similar funds

Bailard's Q2 2022 Portfolio in Review

As of Q2 2022, Bailard held 847 positions worth $2.54B, down 15% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bailard's Q2 2022 filing shows 132 new, 213 increased, 233 reduced and 169 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 813,570 shares worth $67.4M. The largest sale was SPDR Gold Trust, an estimated $76.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q2 2022 buy was iShares 1-3 Year Treasury Bond ETF: 813,570 shares worth $67.4M.
  • Bailard added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2022, an estimated $140M increase.
  • Bailard's biggest Q2 2022 reduction was SPDR Gold Trust, cutting an estimated $76.3M.
  • Bailard fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $3.67M.
  • Bailard's ten largest holdings make up 32% of its $2.54B portfolio in Q2 2022.
  • Bailard opened 132 new positions and closed 169 in Q2 2022.
  • Bailard's portfolio value fell 15% quarter-over-quarter to $2.54B.

Based on Bailard's 13F filing for Q2 2022, filed 27 Jul 2022.